CrowdStrike Holdings (CRWD) filed a Form 8-K with the US Securities and Exchange Commission on August 26, 2026. Subject of the filing: results for the period. The stock closed at $189.18, up 2.0% on the day, on $2.6bn of turnover.
On the same day, insiders sold $4m of the stock — the largest Kurtz George, President and CEO, at $4m. Whether that and the price move are connected is not something the filings say; they record the transaction and its date, nothing more.
Across twelve months the stock has traded between $87.56 and $225.53, and today leaves it 74% up that band — neither end of it. The peak was August 13, 2026 (9 sessions ago), the floor February 24, 2026 (131 sessions ago).
The stock is down 6.2% over five sessions, up 5.0% over a month, up 78.7% over the year. The week and the year point in opposite directions. It closed below its thirty-day average price by 5.7%.
Intraday the stock covered 5.3%, in line with its 4.5% thirty-session norm, so the move arrived without unusual swings. The close held 79% of the way up the day's range into the bell.
Worth $206bn, the company sits 17 of 156 by size within technology. The sector as a whole finished +0.2%, leaning the same way.
From an open of $182.75 the price ranged down to $181.24 and up to $191.32 before closing on $189.18. That is 116.1% above the year's $87.56 floor and 16.1% under its $225.53 ceiling.
Turnover of $2.6bn compares with $1.5bn on an average session for this stock. Against the year, today ranks between the +12.8% best and the -9.9% worst day.
Recent form has been the other way, 20 of the last thirty sessions closing down against 10 up. Its strongest single day in the past year was +12.8% on September 18, 2025, its weakest -9.9% on February 23, 2026.
Its size-neighbours in the sector did not follow — International Business Machines (IBM) -1.8% and Sandisk (SNDK) +1.3% — which argues for something particular to this company. CRWD placed 24th of 986 on money traded.
This text was generated automatically from the closing data. It contains no forecasts and no investment advice — only what the numbers say. Do your own research.